Skip to content Skip to footer

Icon

Target identification

Natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.
Icon

Compound screening

Natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.
Icon

Preclinical testing

Natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.
Who We Are

We are dedicated to the very fine points of clinical research

About Us

Welcome to Eminat Research Group

We are committed to furthering the standard of medical knowledge by way of meticulous and insightful clinical research studies. We surpass current standards in excellence with a well-qualified group of investigators who take on studies of higher complexity and sophistication.

We are dedicated to the very fine points of clinical research and our depth of knowledge sets us apart. Our unparalleled pursuit of excellence is evident in our innovative strategy for designing and executing clinical trials that play a role in shaping the ever-changing healthcare
environment.

Come along with us on a journey toward where expertise meets innovation, and where dedication to excellence delivers breakthroughs that drive the stakes up in patient care. Eminat
Research Group – where knowledge like you’ve never witnessed shapes the future of clinical
research.

Advancing medicine,

innovating to improve lives

Precision in Discovery. Compassion in Practice. Over 25 Years of Clinical Excellence Across Borders.

At Eminat, we don’t just conduct research—we shape the future of medicine. With more than 25 years of experience, a network of over 450,000 patients worldwide, and a reputation built on precision, ethics, and innovation, Eminat Research Group is a trusted partner for both patients and pharmaceutical companies.

From our headquarters in Miramar, Florida, we bridge communities and clinical advancements, offering a full spectrum of services—from biospecimen collection and biobank management to full-service clinical trial execution for complex studies.

Sandra V. Negrete

Founder and CEO of Eminat Research Group

0 +
Years of clinical research leadership
0 +
global patient connections
Advanced biospecimen and biobank capabilities
Fully FDA, EMA, GCP, and GLP compliant
Strategic partner for pharmaceutical, biotech & CROs
Bilingual staff and multicultural patient engagement
Contact Us

Have questions?
Get in touch!

    From our blog

    News and insights

    Top 5 challenges in modern drug discovery
    Sed ut perspiciatis unde omnis iste natus ut perspic iatis…
    From concept to cure: drug discovery steps
    Sed ut perspiciatis unde omnis iste natus ut perspic iatis…
    Emerging trends in targeted drug discovery
    Sed ut perspiciatis unde omnis iste natus ut perspic iatis…
    Receive News

    Subscribe for the Updates!

    Receive News

    Subscribe for the Updates!